Nura Bio logo

Nura Bio

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$68M


Nura Bio Inc. develops neuroprotective therapies for neurological diseases, with a focus on advancing their lead candidate, a brain-penetrant SARM1 inhibitor.

Total Funding

$140M

Headquarters

South San Francisco, USA

Founded

N/A

Focus Areas

neuroprotective therapies
neurological diseases
brain-penetrant SARM1 inhibitor
clinical-stage
biopharmaceutical
Phase 1 studies

Investors

The Column Group logo
Sanofi Ventures logo
Euclidean Capital logo
Samsara Bio Capital logo